Clinical trial
Edaravone in the Treatment of Optic Neuritis
NCT05540262 is registered in ClinicalTrials.gov with First Affiliated Hospital of Guangxi Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Edaravone in the Treatment of Optic Neuritis
- Lead sponsor
- First Affiliated Hospital of Guangxi Medical University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 15, 2022
- Completion date
- December 31, 2025
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.